Japan's Takeda to purchase U.S. cancer drugmaker ARIAD for $5.2B
Monday, January 9, 2017 - 10:01
in Mathematics & Economics
Andrew V. PestanoCAMBRIDGE, Mass., Jan. 9 (UPI) -- Japan's Takeda Pharmaceutical Co. said it will purchase U.S.-based cancer drugmaker ARIAD Pharmaceuticals for about $5.2 billion.